Copyright (c) 2013 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=npspLatest Financial News for NPS Pharmaceuticals, Inc.en-USTue, 18 Jun 2013 00:00:00 GMThttp://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gifhttp://finance.yahoo.com/q/h?s=npsp14445http://us.rd.yahoo.com/finance/news/rss/story/*http://yahoo.ar.wilink.com?ticker=NPSP&mkt_code=YAH-HDLN-A&1371615671yahoo_finance/1301510040Tue, 18 Jun 2013 00:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/mp#npspyahoo_finance/1026843310Mon, 17 Jun 2013 12:08:06 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/findings-presented-endo-2013-support-120000025.html[Business Wire] - NPS Pharmaceuticals, Inc. , a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, yesterday presented findings supporting the therapeutic potential of Natpara® in poster sessions at ENDO 2013, The Endocrine Society’s 95th Annual Meeting in San Francisco, CA.yahoo_finance/1287407024Mon, 17 Jun 2013 12:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/initial-findings-paradox-largest-most-120000320.html[Business Wire] - NPS Pharmaceuticals, Inc. , a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, yesterday presented initial findings from PARADOX, which is believed to be the largest and most comprehensive collection of research to date analyzing the burden of illness for hypoparathyroidism.yahoo_finance/3214243533Mon, 17 Jun 2013 12:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharmaceuticals-president-ceo-dr-172000893.html[Business Wire] - NPS Pharmaceuticals, Inc. , a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief executive officer Francois Nader, M.D.yahoo_finance/2896559945Fri, 14 Jun 2013 17:20:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharmaceuticals-present-hypoparathyroidism-data-121920298.htmlyahoo_finance/3377570781Wed, 05 Jun 2013 12:19:20 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharmaceuticals-present-data-natpara-121100346.html[Business Wire] - NPS Pharmaceuticals, Inc., a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported that twyahoo_finance/1400465516Wed, 05 Jun 2013 12:11:00 GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=131chkadf/*http://beta.fool.com/drkkd/2013/06/04/the-profitable-business-of-developing-orphan-drugs/35871/?source=eogyholnk0000001yahoo_finance/3506971935Tue, 04 Jun 2013 14:58:19 GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12immmn7s/*http://www.thestreet.com/story/11941036/1/nps-reaches-new-52-week-high-npsp.html?puc=yahoo&cm_ven=YAHOOyahoo_finance/2344374235Tue, 04 Jun 2013 14:21:00 GMThttp://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=13git5e6b/*http://wallstcheatsheet.com/stocks/jim-cramer-buy-us-airways-honeywell-dollar-general-and-these-2-stocks.html/?ref=YFyahoo_finance/2631811244Mon, 03 Jun 2013 14:25:05 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=134ke6i01/*http://seekingalpha.com/article/1476051-nps-pharmaceuticals-don-t-fret-about-the-295-000-price-tag?source=yahooyahoo_finance/1623969088Mon, 03 Jun 2013 10:26:09 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=138k0rri3/*http://seekingalpha.com/article/1475161-cramer-s-lightning-round-component-plays-are-dangerous-5-31-13?source=yahooyahoo_finance/3613519990Sun, 02 Jun 2013 11:18:41 GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=131cnc6qt/*http://www.thestreet.com/story/11937713/1/mad-money-lightning-round-dont-sell-weyerhaeuser.html?puc=yahoo&cm_ven=YAHOOyahoo_finance/4215435609Sat, 01 Jun 2013 10:00:00 GMThttp://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=112q5f5bl/*http://www.cnbc.com/id/100781293?__source=yahoo|finance|headline|headline|story&par=yahoo&doc=100781293|Lightning+Round:+US+Airwayahoo_finance/2523273256Fri, 31 May 2013 22:40:46 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharmaceuticals-joins-hypoparathyroidism-association-130000831.html[Business Wire] - NPS Pharmaceuticals, Inc. , a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced its support for World Hypoparathyroidism Awareness Day, which encourages patients, physicians, and caregivers to increase awareness of the disorder and the need for more education, improved diagnosis, and new, long-term treatment ...yahoo_finance/693255500Fri, 31 May 2013 13:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharmaceuticals-present-jefferies-global-201000933.html[Business Wire] - NPS Pharmaceuticals, Inc. will present at the Jefferies 2013 Global Healthcare Conference in New York on Monday, June 3, 2013 at 10:00 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded.yahoo_finance/3943876243Wed, 29 May 2013 20:10:00 GMThttp://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=14bf34oqh/*http://seekingalpha.com/article/1467701-nps-pharmaceuticals-management-presents-at-38th-annual-dbaccess-health-care-conference-transcript?source=yahoo[at Seeking Alpha] - NPS Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript)yahoo_finance/2070195094Wed, 29 May 2013 17:31:07 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharmaceuticals-announces-exercise-over-201500793.html[Business Wire] - NPS Pharmaceuticals, Inc. today reported that it has closed its recently announced public offering of common stock. The total number of shares sold was 6,900,000, comprised of 6,000,000 shares of common stock initially offered and an additional 900,000 shares of common stock sold pursuant to the underwriters’ exercise of their over-allotment option, at the public offering price of $14.53 per share....yahoo_finance/2433550829Tue, 28 May 2013 20:15:00 GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12scc5p79/*http://www.fool.com/investing/general/2013/05/23/nps-pharmaceuticals-issues-new-stock.aspx?source=eogyholnk0000001yahoo_finance/3256516046Fri, 24 May 2013 02:15:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/nps-pharma-prices-offering-224003239.htmlyahoo_finance/2319763717Thu, 23 May 2013 22:40:03 GMT